1. Home
  2. RNTX vs LIVE Comparison

RNTX vs LIVE Comparison

Compare RNTX & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

42.9M

Sector

Health Care

ML Signal

HOLD

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$13.14

Market Cap

41.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
RNTX
LIVE
Founded
2001
1968
Country
United States
United States
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
42.9M
41.2M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
RNTX
LIVE
Price
$1.70
$13.14
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
118.7K
2.9K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
158.14
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$7.03
52 Week High
$2.22
$25.88

Technical Indicators

Market Signals
Indicator
RNTX
LIVE
Relative Strength Index (RSI) 69.15 47.54
Support Level $1.08 $11.80
Resistance Level $2.18 $14.14
Average True Range (ATR) 0.19 0.82
MACD 0.04 0.20
Stochastic Oscillator 83.78 49.93

Price Performance

Historical Comparison
RNTX
LIVE

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company of diversified businesses. It acquires and operates companies with a history of earnings power across five segments: Retail-Entertainment, Retail-Flooring, Flooring Manufacturing, Steel Manufacturing, and Corporate & Other. Retail-Entertainment offers new and pre-owned movies, video games, music, books, comics and collectibles through an integrated buy-sell-trade model. Retail-Flooring is a retailer and installer of flooring, carpeting, and countertops, serving consumers, builders, and contractors. Flooring Manufacturing produces and distributes carpet and hard-surface flooring. Steel Manufacturing engages in steel production and fabrication, generating the majority of revenue. Corporate & Other covers corporate costs and legacy products and services.

Share on Social Networks: